Valuation: Astal Laboratories Limited

Market Cap 3.05B 31.63M 28.1M 26.2M 23.89M 45.07M 45.49M 318M 123M 1.55B 119M 116M 4.99B P/E 2025
9.45x
P/E 2026 8.37x
Enterprise Value 3.54B 36.74M 32.64M 30.43M 27.75M 52.35M 52.84M 369M 143M 1.8B 138M 135M 5.8B EV / Sales 2025
1.36x
EV / Sales 2026 1.31x
Free-Float
41%
Yield 2025 *
-
Yield 2026 -
1 day-1.93%
1 week-0.66%
Current month-1.93%
1 month-10.72%
3 months-21.01%
6 months+0.06%
Current year-19.93%
1 week 68
Extreme 68
72
1 month 62.8
Extreme 62.8
80.35
Current year 60.45
Extreme 60.45
91.9
1 year 60.45
Extreme 60.45
103.2
3 years 32.05
Extreme 32.05
131.7
5 years 5.41
Extreme 5.41
131.7
10 years 5.41
Extreme 5.41
131.7
Manager TitleAgeSince
Director of Finance/CFO 51 2023-07-14
Director TitleAgeSince
Director/Board Member - 2022-09-07
Director/Board Member - 2022-09-07
Director/Board Member - 2022-09-07
Change 5-day change 1-year change 3-year change Capi.($)
-1.93%-0.66%-16.23%+116.97% 31.63M
-0.61%-3.30%+38.46%+112.77% 1,025B
-1.02%-5.41%+37.61%+64.39% 623B
+1.11%-0.87%+7.55%+76.32% 459B
+0.34%-2.49%+60.10%+40.17% 355B
-0.95%-4.87%+22.46%+38.03% 336B
-1.46%-2.20%+11.84%+23.94% 270B
-1.35%-4.27%-4.55%+6.92% 247B
-1.04%-0.74%+35.02%+49.96% 220B
-1.87%-3.31%+30.22%+93.14% 183B
Average -0.49%-1.77%+22.25%+62.26% 371.83B
Weighted average by Cap. -0.12%-2.11%+29.72%+68.32%

Financials

2025 2026
Net sales 637M 6.61M 5.87M 5.48M 4.99M 9.42M 9.51M 66.38M 25.73M 325M 24.82M 24.28M 1.04B 2.49B 25.82M 22.94M 21.39M 19.5M 36.79M 37.13M 259M 100M 1.27B 96.93M 94.83M 4.08B
Net income 89.25M 927K 823K 768K 700K 1.32M 1.33M 9.31M 3.61M 45.51M 3.48M 3.4M 146M 147M 1.53M 1.36M 1.27M 1.15M 2.18M 2.2M 15.34M 5.95M 75.01M 5.73M 5.61M 241M
Net Debt 115M 1.2M 1.06M 993K 905K 1.71M 1.72M 12.03M 4.66M 58.84M 4.5M 4.4M 189M 492M 5.11M 4.54M 4.23M 3.86M 7.28M 7.35M 51.3M 19.88M 251M 19.18M 18.76M 807M
Logo Astal Laboratories Limited
Astal Laboratories Limited is an India-based company, which is engaged in the manufacturing and sale of pharmaceutical intermediates and bulk drugs. The Company is engaged in manufacturing fine chemicals, specialty chemicals and pharmaceutical intermediates. The Company’s products include HF Acid (2-Chloro-1,3-Bis (Dimethylamino) Trimethinium Hexafluorophosphate); 4-Methyl Sulphonyl Phenyl Acetic acid, (1R,3R)-methyl 1-(benzo[d][1,3] dioxol-5-yl)- 2,3,4,9-tetrahydro-1 H-pyrido[3,4-b]indole-3- carboxylate hydrochloride; L-Valine methyl ester Hydrochloride (LVMH); L-Valine benzyl ester Hydrochloride; N-[(2-Cyanobiphenyl-4-methyl)- L-Valine methyl ester Hydrochloride; D-Tryptophan Methyl Ester Hydrochloride; Moc-L-valine (N-(Methoxycarbonyl)-L-valine); 2-Ethoxyethyl-4-methylbenzene sulfonate; 2 Piperidin-4-yl-1H-benzoimidazole; Alpha, alpha-Dimethyl Phenyl Acetic Acid (2-Methyl-2-phenylpropionic acid); 2-(4-bromophenyl)-2-methylpropionic acid; Methyl 2,2-dimethylphenylacetate, and others.
Employees
22
Date Price Change Volume
26-10-01 ₹69.54 -1.93% 2,708
26-09-30 ₹70.91 +1.81% 5,759
26-09-29 ₹69.65 -1.92% 7,819
26-09-28 ₹71.01 -0.85% 14,222
26-09-25 ₹71.62 +2.31% 4,531
  1. Stock Market
  2. Stocks
  3. MACINTR Stock